The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodialysis Anxiety Disorders Behavior Behavioral Symptoms Color Therapy Depression Mental Disorders

Age range

18 week and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fırat University

Elâzığ, Merkez, 23119, Turkey (Türkiye)

About this study

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Be on hemodialysis treatment for at least 6 months,
No sleeping pills or sedative medication,
No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
The patient or someone living in the same household with the patient is literate,
Patients have no vision problems,
Patients must be 18 years of age or older.

Exclusion criteria

Being on hemodialysis treatment for less than 6 months,
Taking sleeping pills or sedative medication,
Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
Illiteracy of the patient and relatives,
Patients have vision problems,
Refusing to participate in the research,
Under 18 years of age

Treatment and study plan

Color Therapy

Other

In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.

Primary outcomes

Depression Anxiety Stress-21 scale (DASS-21)

Time frame: 8 week

The 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 "not applicable to me", 1 "somewhat applicable to me", 2 "generally applicable to me", and 3 "completely applicable to me".
Short Form-12 (SF-12) Quality of Life Scale

Time frame: 8 week

Ware et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function

Sponsors and collaborators

Lead sponsor

Erzincan Binali Yildirim Universitesi

Other

Registry information

Acronym: Color Therapy

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Mar 17, 2025
Registry last updated: Mar 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed